# James M. Reuben

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-m-reuben/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,682 |
| Field | Cancer Cells and Metastasis |
| h-index | 72 |
| i10-index | 188 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5040423978 |
| ORCID iD | https://orcid.org/0000-0001-8972-2103 |
| Works | 431 |

## Researcher papers

- [Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia](https://scholariq.org/papers/lenalidomide-induces-complete-and-partial-remissions-in-patients-with-relapsed/)

## Researcher topics

- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.